- How is the industry approaching diversity and what should the primary focus be?
- Increasing accessibility to trials whilst simultaneously maintaining an appropriate level of patient safety
- Assessing the link between restrictive eligibility criteria and rates of serious adverse events to make informed decisions on expanding exclusion conditions
- Alternative solutions to improve patient numbers amidst pressures to hit recruitment milestones
- How have increased pressures of patient recruitment lead to the questioning of traditional enrollment methods?
Chair: Cathy Scharf, Patient Advocate, Patient Advocates of the East Bay